Pharma & Healthcare Market Research Report

Report Filter Reset All

Sort By Price

Published Date

Category

Clear All

Publishers

Clear All

Report Type

Continents

Clear All

Regions

Clear All

Countries

Clear All

Pharma & Healthcare

Global Aldesleukin Market Professional Survey Report 2019

Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleu...

$3,500.00 04 October, 2019 | QYResearch

Global Aldesleukin Market Professional Survey Report 2019

$3,500.00 | 04 October, 2019 | QYResearch

Aldesleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the huma...

Pharma & Healthcare

Global Lanreotide Market Professional Survey Report 2019

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome The glob...

$3,500.00 04 October, 2019 | QYResearch

Global Lanreotide Market Professional Survey Report 2019

$3,500.00 | 04 October, 2019 | QYResearch

Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome...

Pharma & Healthcare

Global Pegvisomant Market Professional Survey Report 2019

Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market was valued at xx...

$3,500.00 04 October, 2019 | QYResearch

Global Pegvisomant Market Professional Survey Report 2019

$3,500.00 | 04 October, 2019 | QYResearch

Pegvisomant(trade name Somavert) is a growth hormone receptor antagonist used in the treatment of acromegaly. The global Pegvisomant market was va...

Pharma & Healthcare

Global Acromegaly Therapeutics Market Professional Survey Report 2019

Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for Acromegaly....

$3,500.00 04 October, 2019 | QYResearch

Acromegaly is a disorder that results from excess growth hormone (GH) after the growth plates have closed. In this report, we study the drugs for A...

Pharma & Healthcare

Global Besponsa Market Professional Survey Report 2019

Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Besponsa market ...

$3,500.00 04 October, 2019 | QYResearch

Global Besponsa Market Professional Survey Report 2019

$3,500.00 | 04 October, 2019 | QYResearch

Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Bespon...

Pharma & Healthcare

Global Gemtuzumab Ozogamicin Drugs Market Professional Survey Report 2019

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The...

$3,500.00 04 October, 2019 | QYResearch

Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to ...

Pharma & Healthcare

Global Trisenox Market Professional Survey Report 2019

Trisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocytic leukae...

$3,500.00 04 October, 2019 | QYResearch

Global Trisenox Market Professional Survey Report 2019

$3,500.00 | 04 October, 2019 | QYResearch

Trisenox is a chemotherapy drug and is also called Trisenox or ATO. It is a treatment for a type of acute myeloid leukaemia called acute promyelocy...

Pharma & Healthcare

Global Revcovi Market Professional Survey Report 2019

Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The global Revco...

$3,500.00 04 October, 2019 | QYResearch

Global Revcovi Market Professional Survey Report 2019

$3,500.00 | 04 October, 2019 | QYResearch

Revcovi is indicated for the treatment of adenosine deaminase severe combined immune deficiency (ADA-SCID) in pediatric and adult patients. The gl...

Pharma & Healthcare

Global Ebola Treatment Market Professional Survey Report 2019

Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequ...

$3,500.00 04 October, 2019 | QYResearch

Global Ebola Treatment Market Professional Survey Report 2019

$3,500.00 | 04 October, 2019 | QYResearch

Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease w...

Pharma & Healthcare

Global Multiple Sclerosis Therapeutics Market Professional Survey Report 2019

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks the protec...

$3,500.00 04 October, 2019 | QYResearch

Multiple sclerosis (MS) is a potentially disabling disease of the brain and spinal cord (central nervous system). In MS, the immune system attacks ...